版本:
中国

BRIEF-Preliminary data from the ongoing open-label XmAB5871 phase 2 pilot study in IgG4-related disease to be presented at American College of Rheumatology (ACR) 2016 annual meeting

Oct 3 Xencor Inc

* Preliminary data from the ongoing open-label XmAB5871 phase 2 pilot study in IgG4-related disease to be presented at American College of Rheumatology (ACR) 2016 annual meeting Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐